XELPROX

Serial Number 79037674
Registration 3348922
404

Registration Progress

Application Filed
Mar 30, 2007
Under Examination
Approved for Publication
Aug 29, 2007
Published for Opposition
Sep 18, 2007
Registered
Dec 4, 2007

Trademark Image

XELPROX

Basic Information

Serial Number
79037674
Registration Number
3348922
Filing Date
March 30, 2007
Registration Date
December 4, 2007
Published for Opposition
September 18, 2007
Cancellation Date
August 29, 2009
Drawing Code
4000

Status Summary

Current Status
Inactive
Status Code
404
Status Date
Nov 27, 2009

Rights Holder

BAYER SCHERING PHARMA AG

09
Address
Muellerstrasse 178
13353 Berlin
DE

Ownership History

BAYER SCHERING PHARMA AG

Original Applicant
09
DE

BAYER SCHERING PHARMA AG

Owner at Publication
09
DE

BAYER SCHERING PHARMA AG

Original Registrant
09
DE

USPTO Deadlines

Next Deadline
859 days remaining
Section 8 & 9 (20-Year) Renewal Due (Based on registration date 2007-12-04)
Due Date
December 04, 2027
Grace Period Ends
June 04, 2028

Application History

13 events
Date Code Type Description Documents
Aug 27, 2009 DETH P DEATH OF INTERNATIONAL REGISTRATION Loading...
Apr 9, 2008 COC. O CORRECTION UNDER SECTION 7 - PROCESSED Loading...
Apr 8, 2008 PLGL A ASSIGNED TO PARALEGAL Loading...
Dec 4, 2007 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Nov 16, 2007 LIMG M LIMITATION OF GOODS RECEIVED FROM IB Loading...
Sep 18, 2007 PUBO A PUBLISHED FOR OPPOSITION Loading...
Aug 29, 2007 NPUB O NOTICE OF PUBLICATION Loading...
Aug 10, 2007 ALIE A ASSIGNED TO LIE Loading...
Aug 10, 2007 PREV O LAW OFFICE PUBLICATION REVIEW COMPLETED Loading...
Jun 26, 2007 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Jun 20, 2007 DOCK D ASSIGNED TO EXAMINER Loading...
Jun 4, 2007 NWAP I NEW APPLICATION ENTERED Loading...
May 31, 2007 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Additional Information

Other
Statement(s): Column 1, line 8 through 10, "central nervous system and auto-immune diseases, parkinson, and multiple sclerosis" should be deleted.